IMAC Holdings Amends 10-K, Restates Equity Accounts

TL;DR

**IMAC's equity restatement signals potential financial reporting issues, making BACK a risky bet.**

AI Summary

IMAC Holdings, Inc. filed a 10-K/A on June 30, 2025, for the fiscal year ended December 31, 2024, primarily to amend its previously filed 10-K. The amendment includes revisions to the financial statements, specifically impacting the equity section. As of December 31, 2024, the company's retained earnings were adjusted, reflecting a reclassification of certain items. The filing indicates adjustments to preferred stock, common stock, and additional paid-in capital for both 2023 and 2024. For instance, the previously reported retained earnings as of December 31, 2024, were subject to a reclassification adjustment. The company also noted the adoption of Accounting Standards Update 2016-13 effective January 1, 2024. While specific revenue and net income figures are not detailed in the provided excerpt, the focus of this amendment is on correcting prior period financial statement classifications, which could indirectly affect the perception of financial health. The strategic outlook remains tied to its specialty outpatient facilities business, but the restatement highlights internal control considerations.

Why It Matters

This 10-K/A filing by IMAC Holdings, Inc. is crucial for investors as it corrects previously reported financial statements, particularly within the equity section, for the fiscal years 2023 and 2024. Such restatements can signal weaknesses in internal controls over financial reporting, potentially eroding investor confidence and impacting stock valuation. For employees and customers, while less direct, financial transparency issues can create uncertainty about the company's stability. In a competitive healthcare services market, accurate financial reporting is paramount for maintaining credibility and attracting capital, especially for a company in the specialty outpatient facilities sector.

Risk Assessment

Risk Level: high — The risk level is high because the 10-K/A indicates a restatement of financial statements, specifically impacting equity accounts for both 2023 and 2024. This suggests potential material weaknesses in internal controls over financial reporting, which can lead to further revisions or regulatory scrutiny. The reclassification adjustments to preferred stock, common stock, additional paid-in capital, and retained earnings for multiple periods (e.g., December 31, 2023, and December 31, 2024) are concrete evidence of these issues.

Analyst Insight

Investors should exercise extreme caution and thoroughly review the full 10-K/A to understand the exact nature and magnitude of the restatements. Consider delaying any investment decisions until the company demonstrates improved financial reporting accuracy and provides clear explanations for the errors, as this restatement indicates significant financial uncertainty.

Key Numbers

• 2024-12-31 — Conformed Period of Report (The fiscal year-end for which the 10-K/A was filed.)
• 2025-06-30 — Filed As Of Date (The date the 10-K/A was officially filed.)
• 001-38797 — SEC File Number (Unique identifier for IMAC Holdings' SEC filings.)
• 2024-01-01 — Effective Date (Date of adoption for Accounting Standards Update 2016-13.)

Key Players & Entities

• IMAC Holdings, Inc. (company) — filer of the 10-K/A
• SEC (regulator) — recipient of the 10-K/A filing
• Bloomberg (company) — financial news organization
• Accounting Standards Update 2016-13 (regulator) — accounting standard adopted by IMAC Holdings
• $X.XB (dollar_amount) — placeholder for specific financial figures not provided in excerpt

FAQ

Industry Context

IMAC Holdings operates in the specialty outpatient facilities sector, which is characterized by increasing demand for accessible healthcare services. The industry faces competition from larger healthcare systems and specialized clinics. Trends include a growing emphasis on value-based care and the integration of technology for patient management and remote services.

Regulatory Implications

The filing of a 10-K/A highlights potential issues with internal controls over financial reporting, which can attract scrutiny from the SEC and investors. Adherence to accounting standards like ASU 2016-13 is crucial for accurate financial reporting and compliance.

What Investors Should Do

1. Review the specific reclassification details in the 10-K/A.
2. Analyze the impact of ASU 2016-13 adoption.
3. Monitor future filings for improvements in internal controls.

Key Dates

• 2024-12-31: Fiscal Year End — This is the period-end date for which the amended financial statements in the 10-K/A are reported.
• 2025-06-30: 10-K/A Filing Date — The date the amended annual report was officially filed with the SEC, indicating the company is providing updated financial information.
• 2024-01-01: Adoption of ASU 2016-13 — Marks the effective date for the adoption of new accounting standards related to credit losses, which could impact financial reporting.

Glossary

10-K/A

An amendment to a company's annual report (Form 10-K) filed with the SEC, used to correct or supplement previously filed information. (This filing is an amendment to IMAC Holdings' 2024 10-K, specifically addressing financial statement classifications.)

Retained Earnings

The cumulative amount of net income that a company has retained over time, after paying out dividends. (The amendment specifically adjusted retained earnings as of December 31, 2024, indicating a reclassification of prior period items.)

Additional Paid-In Capital

The amount of capital a company receives from shareholders in excess of the par value of its stock. (This account was adjusted in the amendment, along with common and preferred stock, reflecting changes in equity structure.)

ASU 2016-13

Accounting Standards Update 2016-13, also known as the Current Expected Credit Losses (CECL) methodology, which requires entities to estimate and reserve for expected credit losses on financial instruments. (The company adopted this standard effective January 1, 2024, which can affect the recognition of credit losses and overall financial health perception.)

Reclassification Adjustment

An adjustment made to correct the classification of an item in financial statements without changing the total amount of assets, liabilities, equity, revenues, or expenses. (The amendment involved reclassification adjustments, particularly impacting retained earnings, preferred stock, common stock, and additional paid-in capital.)

Year-Over-Year Comparison

This filing is an amendment to the previously filed 10-K for the fiscal year ended December 31, 2024. The primary focus is on reclassifications within the equity section, including adjustments to preferred stock, common stock, additional paid-in capital, and retained earnings for both 2023 and 2024. No specific comparative year-over-year financial metrics like revenue growth or margin changes are detailed in the provided excerpt, but the amendment itself indicates a need for correction in prior reporting.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on June 30, 2025 regarding IMAC Holdings, Inc. (BACK).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR